Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) Assets Average (2017 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Assets Average for 5 consecutive years, with $16.3 million as the latest value for Q3 2021.

  • Quarterly Assets Average rose 295.88% to $16.3 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $16.3 million through Sep 2021, up 295.88% year-over-year, with the annual reading at $8.0 million for FY2020, 10.71% up from the prior year.
  • Assets Average for Q3 2021 was $16.3 million at ENDRA Life Sciences, down from $18.1 million in the prior quarter.
  • The five-year high for Assets Average was $18.1 million in Q2 2021, with the low at $517943.5 in Q1 2017.
  • Average Assets Average over 5 years is $6.4 million, with a median of $4.9 million recorded in 2018.
  • Peak annual rise in Assets Average hit 847.38% in 2018, while the deepest fall reached 71.88% in 2018.
  • Over 5 years, Assets Average stood at $6.8 million in 2017, then plummeted by 37.41% to $4.3 million in 2018, then grew by 26.74% to $5.4 million in 2019, then surged by 30.9% to $7.1 million in 2020, then soared by 130.47% to $16.3 million in 2021.
  • According to Business Quant data, Assets Average over the past three periods came in at $16.3 million, $18.1 million, and $13.8 million for Q3 2021, Q2 2021, and Q1 2021 respectively.